Neuroendocrine breast carcinoma (NEBC) is a rare type of breast cancer, accounting for 2-5% of all invasive breast cancers, and this study analyzes data from 36 NEBC patients diagnosed over 11 years.
The analysis compared these NEBC patients to a larger group of 925 patients with invasive ductal carcinoma, focusing on clinical, pathological, and radiological features, such as imaging results and hormone receptor status.
The findings indicate NEBC's distinct characteristics, revealing that patients are often older and have specific hormone receptor profiles, which may help identify important prognostic factors and lead to future predictive markers for this unique breast cancer subtype.